Dragoslav Sokić

ORCID: 0000-0003-0226-9727
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Pharmacological Effects and Toxicity Studies
  • Neuroscience and Neuropharmacology Research
  • Neurological disorders and treatments
  • Psychosomatic Disorders and Their Treatments
  • Metabolism and Genetic Disorders
  • EEG and Brain-Computer Interfaces
  • Multiple Sclerosis Research Studies
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Genomics and Rare Diseases
  • Cerebrospinal fluid and hydrocephalus
  • Glycogen Storage Diseases and Myoclonus
  • Peripheral Neuropathies and Disorders
  • Neurological and metabolic disorders
  • Glioma Diagnosis and Treatment
  • Infectious Encephalopathies and Encephalitis
  • Restless Legs Syndrome Research
  • Polyomavirus and related diseases
  • Functional Brain Connectivity Studies
  • Syphilis Diagnosis and Treatment
  • Trace Elements in Health
  • Bipolar Disorder and Treatment
  • Reproductive tract infections research
  • Genetic Neurodegenerative Diseases

University of Belgrade
2016-2025

Univerzitetski Klinički Centar Srbije
2002-2025

Centar za Promociju Nauke
2012-2024

University of Belgrade – Faculty of Medicine
2014-2015

Oncology Institute of Vojvodina
2010

University Clinical Centre
1990-2003

Gregory L. Krauss José M. Serratosa Vicente Villanueva Milda Endzinienė Zhen Hong and 95 more Jacqueline A. French Haitao Yang David Squillacote Hannah B Edwards Jin Zhu Antonio Laurenza Samuel F. Berkovic Wendyl D’Souza Terence J. O’Brien Udaya Seneviratne Martin Robinson Plamen Bozinov Ivan Milanov Еkaterina Titianova Zahari Zahariev Liwen Wu Xuefeng Wang Dong Zhou Jindriska Buresova Jan Hadač Petr Marusič Hana Ošlejšková Sulev Haldre Ain Pajos Valentin Sander Inga Talvik Stephan Arnold A. Hufnagel Frank Kerling Holger Lerche Soheyl Noachtar Felix Rosenow Joachim Springub Bernhard J. Steinhoff Konrad J. Werhahn Raymond Tak Fai Cheung Patrick Kwan Ping Wing Ng John S.D. Chan Attila Balogh István Kondákor Magdolna Neuwirth Péter Rajna György Rásonyi Joy Desai Sudhir Kothari Sita Sattaluri Bhawna Sharma Nandan Yardi J. M. K. Murthy Manmohan Mehndiratta Kolichana Venkateshwaralu Silvana Franceschetti Guntis Karelis Guntis Rozentals Baiba Uskane Rūta Mameniškienė Irena Virketiene Zariah Abdul Aziz Kheng Seang Lim Mei‐Ling Sharon Tai Maria Epifania Collantes Katerina Tanya P. Gosiengfiao Anna Członkowska Wiesław Drozdowski Waldemar Fryze Jacek Gawłowicz Maria Mazurkiewicz‐Bełdzińska E Motta Carla Bentes Luı́s Cunha Georgine de Sousa J. M. Lopes Lima Ioana Mı̂ndruță Dezso Nagy Sanda Maria Nica E. D. Belousova Kalinin Vv Е. В. Левитина Perunova Nb Н. В. Пизова И. Е. Повереннова П. Н. Власов Dragoslav Sokić Ksenija Božić N. Jović Žarko Martinović Mirjana Spasić Seung Bong Hong Joong Koo Kang Sang Ho Kim Sung Eun Kim Byung-In Lee Sang Kun Lee Yong Won Cho

To evaluate the efficacy and safety of perampanel 2, 4, 8 mg/day added to 1-3 concomitant antiepileptic drugs (AEDs) in patients with uncontrolled partial-onset seizures.During this double-blind, placebo-controlled trial, persisting seizures on AEDs were randomized or placebo following a 6-week baseline phase. Perampanel was titrated weekly by 2 maintained at dose achieved for 13 weeks. Primary endpoints median percent change seizure frequency 50% responder rate. Analysis covariance...

10.1212/wnl.0b013e318254473a article EN Neurology 2012-04-20
Herm J. Lamberink Willem M. Otte Ingmar Blümcke Kees P. J. Braun Martin Aichholzer and 95 more Isabel Amorim Javier Aparicio Eleonora Aronica Alexis Arzimanoglou Carmen Barba Jürgen Beck Albert J. Becker Jan Beckervordersandforth Christian G. Bien Ingmar Blümcke István Bódi Kees P. J. Braun Hélène Catenoix Francine Chassoux Mathilde Chipaux Thomas Cloppenborg Roland Coras J. Helen Cross Luca De Palma Jane de Tisi Francesco Deleo Bertrand Devaux Giancarlo Di Gennaro Georg Dorfmüller John S. Duncan Christian E. Elger Katharina Ernst Vincenzo Esposito Martha Feucht Željka Petelin Gadže Rita Garbelli Karin Geleijns António Gil‐Nagel Alexander Grote Thomas Grünwald Renzo Guerrini Hajo M. Hamer Mrinalini Honavar Thomas S. Jacques Antonia Jakovčević Leena Jutila Adam Kalina Reetta Kälviäinen Karl Martin Klein Kristina Koenig Pavel Kršek Manfred Kudernatsch Martin Kudr Herm J. Lamberink Kristina Malmgren Petr Marusič A G Melikyan Katja Menzler Soheyl Noachtar Willem M. Otte Çiğdem Özkara Tom Pieper José Pimentel Savo Raičević Sylvain Rheims Joana Ribeiro Felix Rosenow Karl Rössler Bertil Rydenhag Francisco Sales Victoria San Antonio‐Arce Karl Lothar Schaller Olaf Schijns Theresa O. Scholl Johannes Schramm Andreas Schulze–Bonhage Raf Sciot Margitta Seeck L V Shishkina Dragoslav Sokić Nicola Specchio Tom Theys Maria Thom Rafael Toledano Joseph Toulouse Mustafa Uzan J. van Loon Wim Van Paesschen Tim J. von Oertzen Floor E. Jansen Frans S.S. Leijten Peter van Rijen Wim G.M. Spliet Angelika Mühlebner Burkhard S. Kasper Susanne Fauser Tilman Polster Thilo Kalbhenn Daniel Delev Andrew W. McEvoy

10.1016/s1474-4422(20)30220-9 article EN The Lancet Neurology 2020-08-18

Summary: Purpose: In patients with multiple sclerosis (MS), epileptic seizures occur more frequently than in the general population. The aim of this study was to analyze clinical characteristics epilepsy MS, potential correlation between semiology seizures, EEG and magnetic resonance imaging (MRI) findings these patients, as well examine response anticonvulsant therapy. Methods: a series 268 consecutive definite MS hospitalized at Institute Neurology, Belgrade, we identified 20 (7.5%) or...

10.1046/j.1528-1157.2001.48699.x article EN Epilepsia 2001-01-23

In a consecutive series of 169 outpatients with Parkinson9s disease the frequency depression was compared in two groups: those who developed before age 50, and after 50. Major found 36% patients early onset 16% late disease. This significant difference disappeared when both groups were matched for duration A stepwise regression analysis showed correlation only between scores impairment activities daily living.

10.1136/jnnp.57.10.1265 article EN Journal of Neurology Neurosurgery & Psychiatry 1994-10-01

Summary: Purpose: We report the frequency of parkinsonism and cognitive decline (P/CD) in patients treated with valproate (VPA) after 1 year treatment at least follow‐up. Methods: Three hundred sixty‐four various epileptic syndromes seizure types were VPA mono‐ or polytherapy for more than year. Results: found five cases P/CD (1.37%; 95% CI, 0.18–2.56%). Among 140 different adverse effects (AEs) VPA, among rarest but significant terms drug discontinuation (five 17). Conclusions: Early...

10.1111/j.1528-1167.2006.00711.x article EN Epilepsia 2006-10-02

Background/Objectives: Functional seizures (FSs) are paroxysmal, time-limited events with motor, sensory, autonomic, or cognitive manifestations related to pathophysiological processes other than abnormal electric discharges in the brain. However, these often followed by different psychiatric comorbidities. Their impact on overall quality of life and cofounding factors, especially ones that can be treated, were main investigation aims this study. Methods: This study comprised 76 patients who...

10.3390/brainsci15020120 article EN cc-by Brain Sciences 2025-01-26

Summary Objective To examine antioxidative system in hippocampi of patients with mesial temporal lobe epilepsy associated hippocampal sclerosis (mTLE‐HS). Methods Activity and levels enzymes—catalase (CAT), glutathione peroxidase (GPx), reductase (GR), manganese superoxide dismutase (MnSOD), copper‐zinc (CuZnSOD)—were assessed nine pharmacoresistant mTLE‐HS (mean age 37.7 ± [standard deviation] 6.6 years) who underwent amygdalohippocampectomy, 10 obtained via autopsy from five neurologically...

10.1111/epi.12981 article EN Epilepsia 2015-04-09

Background:The diagnosis of epilepsy primarily depends on description the observed seizure. The aim this study was to determine reliability witness' among groups with different medical education.Methods:A group 44 respondents (15 laymen, 15 students, and 14 doctors at neurology residency program) were shown video footages focal epileptic seizure (ES) secondary generalization psychogenic non-epileptic (PNES) same patient. ability describe ES PNES characteristics, estimate duration seizures,...

10.1179/1743132815y.0000000009 article EN Neurological Research 2015-01-16

To determine long-term survival in patients with status epilepticus (SE).We prospectively followed admitted for the first (69.6%) or recursive episode of SE between January 1, 1989 and December 31, 1997 at Institute Neurology, Belgrade, Serbia, until death study termination (December 2006). Data were obtained cause death; etiology SE-acute symptomatic (AS), progressive (PS), remote (RS), idiopathic/cryptogenic (I/C); presence epilepsy; reoccurrence SE. Standardized mortality rate (SMR),...

10.1111/j.1528-1167.2009.02188.x article EN Epilepsia 2009-06-26

Purpose: The application of artificial neural networks in the pharmaceutical sciences is broad, ranging from drug discovery to clinical pharmacy. In this study, we explored applicability counter-propagation (CPANNs), combined with genetic algorithm (GA) for prediction topiramate (TPM) serum levels based on identified factors important its prediction. Methods: study was performed 118 TPM measurements obtained 78 adult epileptic patients. Patients were stable dosing regimen at least 7 days;...

10.18433/j33031 article EN cc-by Journal of Pharmacy & Pharmaceutical Sciences 2015-12-06

Summary Background: To get more insight into the effects of most widely used antiepileptic drugs (AEDs) on prooxidant/ antioxidant balance in epilepsy, a comparative analysis byproducts oxidative damage and de fense mechanisms was performed patients with epilepsy treated lamotrigine, carbamazepine valproic acid. Methods: Byproducts to proteins (reactive carbonyl derivatives, RCD protein thiol groups, PSH), lipids (urinary isoprostanes, 8-epi-PGF2a) DNA 8-hydroxy-2’-deoxyguanosine, 8-OHdG),...

10.2478/jomb-2013-0009 article EN cc-by Journal of Medical Biochemistry 2013-04-01
Coming Soon ...